Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Nakamura

Showing results (491-500 of 709) with videos related to

Pageof 71
Sort By:
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
Chemical Research in Toxicology|January 28, 2014
Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptorNorie Murayama, Rinie van Beuningen, Hiroshi Suemizu, et al.
Cardiovascular and Interventional Radiology|July 8, 2021
24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated StentOsamu Iida, Masahiko Fujihara, Daizo Kawasaki, et al.
Cardiovascular and Interventional Radiology|November 7, 2019
Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX StentsYoshimitsu Soga, Masahiko Fujihara, Osamu Iida, et al.
Hepatology International|September 23, 2018
Prediction of the very early occurrence of HCC right after DAA therapy for HCV infectionYoshihiko Ooka, Kanda Miho, Obi Shuntaro, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 29, 2002
Coronary disease morphology and distribution determined by quantitative angiography and intravascular ultrasound--re-evaluation in a cooperative multicenter intravascular ultrasound study (COMIUS)Masakazu Yamagishi, Hiroaki Hosokawa, Satoshi Saito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[Hepatocellular carcinoma recurrence in PEI site--a case report]Hideo Ota, Hiroaki Nagano, Masato Sakon, et al.
International Journal of Hepatology|December 31, 2014
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including RegimensTatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, et al.
Cellular Signalling|November 28, 2025
Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinomaNa Qiang, Cheng Lan, An Lin, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 4, 2026
Prognostic impact of systolic blood pressure and antithrombotic strategy in patients with atrial fibrillation and stable coronary artery disease: a post-hoc analysis of the AFIRE trialShinichi Yamanaka, Takashi Noda, Kotaro Nochioka, et al.
Pageof 71

Showing results (491-500 of 709) with videos related to

Sort By:
Pageof 71
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
Chemical Research in Toxicology|January 28, 2014
Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptorNorie Murayama, Rinie van Beuningen, Hiroshi Suemizu, et al.
Cardiovascular and Interventional Radiology|July 8, 2021
24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated StentOsamu Iida, Masahiko Fujihara, Daizo Kawasaki, et al.
Cardiovascular and Interventional Radiology|November 7, 2019
Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX StentsYoshimitsu Soga, Masahiko Fujihara, Osamu Iida, et al.
Hepatology International|September 23, 2018
Prediction of the very early occurrence of HCC right after DAA therapy for HCV infectionYoshihiko Ooka, Kanda Miho, Obi Shuntaro, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 29, 2002
Coronary disease morphology and distribution determined by quantitative angiography and intravascular ultrasound--re-evaluation in a cooperative multicenter intravascular ultrasound study (COMIUS)Masakazu Yamagishi, Hiroaki Hosokawa, Satoshi Saito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[Hepatocellular carcinoma recurrence in PEI site--a case report]Hideo Ota, Hiroaki Nagano, Masato Sakon, et al.
International Journal of Hepatology|December 31, 2014
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including RegimensTatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, et al.
Cellular Signalling|November 28, 2025
Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinomaNa Qiang, Cheng Lan, An Lin, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 4, 2026
Prognostic impact of systolic blood pressure and antithrombotic strategy in patients with atrial fibrillation and stable coronary artery disease: a post-hoc analysis of the AFIRE trialShinichi Yamanaka, Takashi Noda, Kotaro Nochioka, et al.
Pageof 71